Patent History
  • Application
    US 12/955627 2010-11-29
  • Publication
    US 2011135663 2011-06-09
Supplementary

published patent: ANTI-IGF-IR ANTIBODIES AND USES THEREOF

TitleANTI-IGF-IR ANTIBODIES AND USES THEREOF
Priority Date2010-11-29 US 12/955627
2009-12-04 US 12/266681P
Inventors
Issue Date2011
Citation
US Published patent application US 2011135663. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite?
AbstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.
Persistent Identifierhttp://hdl.handle.net/10722/177013

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:56Z-
dc.date.available2012-11-30T08:38:56Z-
dc.date.issued2011-
dc.identifier.citationUS Published patent application US 2011135663. Washington, DC: US Patent and Trademark Office (USPTO), 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/177013-
dc.description.abstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleANTI-IGF-IR ANTIBODIES AND USES THEREOFen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorZhang, Men_HK
patents.identifier.applicationUS 12/955627en_HK
patents.description.assigneeUNIV HONG KONG [CN]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2011-06-09en_HK
patents.identifier.hkutechidAIDS-2009-00339-1-
patents.date.application2010-11-29en_HK
patents.date.priority2010-11-29 US 12/955627en_HK
patents.date.priority2009-12-04 US 12/266681Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2011135663en_HK
patents.identifier.publicationUS 8444982-
patents.relation.familyEP 2507263 (A1) 2012-10-10en_HK
patents.relation.familyUS 2011135663 (A1) 2011-06-09en_HK
patents.relation.familyWO 2011066721 (A1) 2011-06-09en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats